Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2013 Financial and Operating Results on March 20, 2014

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\nQUEBEC CITY, March 12, 2014 /CNW Telbec/ - Aeterna Zentaris Inc.\n (NASDAQ: AEZS) (TSX: AEZ) (the \"Company\") will announce its fourth\n quarter and full-year 2013 financial and operating results after market\n close on Thursday, March 20, 2014. The Company will host a conference\n call to discuss these results on Friday, March 21, 2014, at 8:30 a.m.,\n Eastern Time.\n\n\nParticipants may access the live webcast via the Company's website at www.aezsinc.com in the \"Newsroom\" section, or by telephone using the following numbers:\n in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.\n A replay of the webcast will also be available on the Company's website\n for a period of 30 days.\n\n\nAbout Aeterna Zentaris\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in\n developing novel treatments in oncology and endocrinology. The\n Company's pipeline encompasses compounds at various stages of\n development. For more information, visit www.aezsinc.com.\n\n\nSOURCE Aeterna Zentaris Inc.\n\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. 265 [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. 406 [email protected] Copyright CNW Group 2014","length":2173,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.